logo.png
GLUCOTRACK ANNOUNCES PRECLINICAL TESTING WITH IMPLANTABLE CONTINUOUS GLUCOSE MONITOR
12 oct. 2023 08h30 HE | GlucoTrack, Inc.
Rutherford, NJ, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on glucose monitoring technologies for people with...
SeaStar_SM_LogoCard.png
SeaStar Medical to Present at the Dawson James Small Cap Growth Conference on October 12, 2023
05 oct. 2023 08h30 HE | SeaStar Medical Holding Corporation
DENVER, Oct. 05, 2023 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a medical device company developing proprietary solutions to reduce the consequences of hyperinflammation...
logo.png
GLUCOTRACK ANNOUNCES THE APPOINTMENT OF ERIN CARTER TO BOARD OF DIRECTORS
31 août 2023 08h30 HE | GlucoTrack, Inc.
Rutherford, NJ, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on glucose monitoring technologies for people with...
logo.png
GLUCOTRACK ANNOUNCES NEW VP OF MARKETING
28 août 2023 09h00 HE | GlucoTrack, Inc.
Rutherford, NJ, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on glucose monitoring technologies for people with...
SeaStar_SM_LogoCard.png
SeaStar Medical to Hold Business Update Conference Call Today at 4:00 p.m. Eastern Time
22 août 2023 08h00 HE | SeaStar Medical Holding Corporation
DENVER, Aug. 22, 2023 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (“SeaStar Medical” or the “Company”), a medical device company developing proprietary solutions to reduce...
SeaStar_SM_LogoCard.png
SeaStar Medical Reports Second Quarter 2023 Financial Results and Provides a Business Update
14 août 2023 16h35 HE | SeaStar Medical Holding Corporation
Management to hold a business update conference call on August 22 beginning at 4:00 p.m. Eastern time DENVER, Aug. 14, 2023 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU)...
SeaStar_SM_LogoCard.png
SeaStar Medical to Sponsor the Critical Care Time Podcast Series Covering Vital Medical Issues for Healthcare Professionals Who Care for Critically Ill Patients
30 juin 2023 08h00 HE | SeaStar Medical Holding Corporation
DENVER, June 30, 2023 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a medical device company developing proprietary solutions to reduce the consequences of hyperinflammation...
SeaStar_SM_LogoCard.png
SeaStar Medical to Present at the Maxim Group Virtual Healthcare Conference Hosted by M-Vest on June 21, 2023
14 juin 2023 08h00 HE | SeaStar Medical Holding Corporation
DENVER, June 14, 2023 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a medical device company developing proprietary solutions to reduce the consequences of hyperinflammation...
SeaStar_SM_LogoCard.png
SeaStar Medical Reports First Quarter 2023 Financial Results and Provides a Business Update
15 mai 2023 16h45 HE | SeaStar Medical Holding Corporation
DENVER, May 15, 2023 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (“SeaStar Medical” or the “Company”), a medical device company developing proprietary solutions to reduce...
SeaStar_SM_LogoCard.png
SeaStar Medical to Present at the JMP Securities Life Sciences Conference on May 16, 2023
10 mai 2023 08h00 HE | SeaStar Medical Holding Corporation
DENVER, May 10, 2023 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a medical device company developing proprietary solutions to reduce the consequences of hyperinflammation...